Pediatric Endocrine Society (PES 2026) 30 April - 3 May 2026

Once-weekly somapacitan in children with turner syndrome (REAL8): a randomised, phase 3 Trial

Authors :

Nelly Mauras1, Claudia Boettcher2, Michael Højby3, Kamil Soltysik3, Alexander AL Jorge4, Kenichi Kashimada5, Agnès Linglart6, Xiaoping Luo7, Philip G Murray8,9, Philippe Backeljauw10

Affiliations
View Details Hide Details
{{ getPageNum(PDFPage) }}
Keywords
Rare Endocrine Disorder
Congress oral presentation
Somapacitan